Auriga Raises PT on Celgene to $82

Symbols: CELG
Tags: Auriga
Share

Auriga has raised the price target on Celgene (NASDAQ: CELG) from $71 to $82 and maintains its Buy rating.


 
 
< Previous
Guggenheim Downgrades PulteGroup to Neutral
Next >
Auriga Lowers PT on Globe Specialty Metals to $17
Share
Printer-friendly version
Send to friend
We're Loving

Benzinga's Premium Memberships

Benzinga's News Delivered Free

Brain Trust